Benzinga's Top Initiations

Analysts at UBS initiated coverage on shares of Concert Pharmaceuticals

with a “buy” rating. The target price for Concert Pharma is set to $25. Concert Pharma's shares closed at $14.88 on Friday. HC Wainwright initiated coverage on shares of BioCryst Pharmaceuticals

with a “buy” rating. The target price for BioCryst Pharmaceuticals is set to $21. BioCryst's shares closed at $11.46 on Friday. Analysts at Cantor Fitzgerald initiated coverage on shares of Eagle Pharmaceuticals

with a “buy” rating. The target price for Eagle Pharma is set to $21. Eagle Pharma's shares closed at $14.92 on Friday. Deutsche Bank initiated coverage on shares of Installed Building Products

with a “buy” rating. The target price for Installed Building Products is set to $18. Installed Building's shares closed at $14.78 on Friday.